Literature DB >> 29781976

POSTERIOR SCLERAL CONTRACTION TO TREAT RECURRENT OR PERSISTENT MACULAR DETACHMENT AFTER PREVIOUS VITRECTOMY IN HIGHLY MYOPIC EYES.

Linyan Zheng1, Anpeng Pan, Shuangqian Zhu, Yue Wu, Liang Dong, Anquan Xue.   

Abstract

PURPOSE: To determine the efficacy of posterior scleral contraction (PSC) to treat recurrent or persistent macular detachment after previous vitrectomy in highly myopic eyes.
METHODS: We reviewed the medical records of patients with high myopia and recurrent or persistent macular detachment after previous vitrectomy treated with PSC at our hospital between April 2013 and March 2017. Fourteen eyes (14 patients; mean age, 58.93 ± 11.08 years) were included. Sclera cross-linked with genipin was used for PSC. The desired axial length decrease was 0.1-fold. The reattachment rate, best-corrected visual acuity, and axial length changes were evaluated.
RESULTS: The macular reattachment rate was 100%. In seven eyes with a silicone oil tamponade, the oil was successfully removed 2 weeks to 4 months after surgery. The best-corrected visual acuity improved significantly postoperatively (Snellen acuity improved from 20/1,000-20/400) (1.75 ± 0.90 vs. 1.34 ± 0.58 logarithm of the minimal angle of resolution; P < 0.05). Eight eyes (57.14%) improved; six eyes (43.86%) remained stable. The axial length decreased significantly postoperatively (31.32 ± 3.04 vs. 29.08 ± 3.05 mm; P < 0.05).
CONCLUSION: Posterior scleral contraction is safe and effective for recurrent and persistent macular detachment after previous vitrectomy in highly myopic eyes. The silicone oil is removed after PSC, and vision can be preserved in these refractory cases.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29781976     DOI: 10.1097/IAE.0000000000002217

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  2 in total

1.  Posterior scleral contraction to treat myopic traction maculopathy at different stages.

Authors:  Shuangqian Zhu; Anquan Xue; Haoyu Li; Jie Ye; Anpeng Pan; Jingwei Zheng; Guoxu Xu
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

2.  Posterior scleral reinforcement for the treatment of myopic traction maculopathy.

Authors:  Qing He; Xiu Wang; Qianhui Shi; Caiyuan Xie; Anquan Xue; Ruihua Wei
Journal:  BMC Ophthalmol       Date:  2022-06-21       Impact factor: 2.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.